Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-18

Clinical Trial Update: Mitochondrial Complex I Dysfunction in PWS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating mitochondrial complex I dysfunction in Prader-Willi syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Prader-Willi Syndrome | Phase 2 | Status: WITHDRAWN